Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Methylation profiles reveal distinct subgroup of hepatocellular carcinoma patients with poor prognosis.

Mah WC, Thurnherr T, Chow PK, Chung AY, Ooi LL, Toh HC, Teh BT, Saunthararajah Y, Lee CG.

PLoS One. 2014 Aug 5;9(8):e104158. doi: 10.1371/journal.pone.0104158. eCollection 2014. Erratum in: PLoS One. 2016;11(1):e0146690.

2.

Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma.

Song MA, Tiirikainen M, Kwee S, Okimoto G, Yu H, Wong LL.

PLoS One. 2013;8(2):e55761. doi: 10.1371/journal.pone.0055761. Epub 2013 Feb 20.

3.

Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips.

Shen J, Wang S, Zhang YJ, Wu HC, Kibriya MG, Jasmine F, Ahsan H, Wu DP, Siegel AB, Remotti H, Santella RM.

Epigenetics. 2013 Jan;8(1):34-43. doi: 10.4161/epi.23062. Epub 2012 Dec 3.

4.

Aberrant methylation of TRIM58 in hepatocellular carcinoma and its potential clinical implication.

Qiu X, Huang Y, Zhou Y, Zheng F.

Oncol Rep. 2016 Aug;36(2):811-8. doi: 10.3892/or.2016.4871. Epub 2016 Jun 13.

PMID:
27373520
5.

Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.

Lu CY, Hsieh SY, Lu YJ, Wu CS, Chen LC, Lo SJ, Wu CT, Chou MY, Huang TH, Chang YS.

Genes Chromosomes Cancer. 2009 Dec;48(12):1057-68. doi: 10.1002/gcc.20708.

PMID:
19760608
6.

Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.

Lee S, Lee HJ, Kim JH, Lee HS, Jang JJ, Kang GH.

Am J Pathol. 2003 Oct;163(4):1371-8.

7.

Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.

Yu J, Ni M, Xu J, Zhang H, Gao B, Gu J, Chen J, Zhang L, Wu M, Zhen S, Zhu J.

BMC Cancer. 2002 Nov 15;2:29. Epub 2002 Nov 15.

8.

Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.

Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A, Cong W, Liu C, Wang H, Wu M, Zhao J, Guo Y.

Clin Cancer Res. 2008 Nov 15;14(22):7405-12. doi: 10.1158/1078-0432.CCR-08-0409.

9.

Aberrant CpG island hypermethylation and down-regulation of Oct-6 mRNA expression in human hepatocellular carcinoma.

Sun JZ, Yang XX, Li XH, Xu WW, Wang Y, Zhu W, Li M.

Dig Dis Sci. 2011 Oct;56(10):3072-7. doi: 10.1007/s10620-011-1686-y. Epub 2011 Mar 30.

PMID:
21448695
10.

[Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma].

Liu WJ, Wang L, Wang JP, Li JQ, Zhang CQ, Zheng L, Yuan YF.

Ai Zheng. 2006 Jun;25(6):696-700. Chinese.

PMID:
16764763
11.

Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.

Shimizu D, Kanda M, Nomoto S, Oya H, Takami H, Hibino S, Suenaga M, Inokawa Y, Hishida M, Takano N, Nishikawa Y, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y.

Oncol Rep. 2014 Mar;31(3):1305-13. doi: 10.3892/or.2013.2939. Epub 2013 Dec 20.

PMID:
24366000
12.

DNA binding protein A expression and methylation status in hepatocellular carcinoma and the adjacent tissue.

Yasen M, Obulhasim G, Kajino K, Mogushi K, Mizushima H, Tanaka S, Tanaka H, Hino O, Arii S.

Int J Oncol. 2012 Mar;40(3):789-97. doi: 10.3892/ijo.2011.1282. Epub 2011 Dec 6.

PMID:
22159460
13.

Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors.

Hernandez-Vargas H, Lambert MP, Le Calvez-Kelm F, Gouysse G, McKay-Chopin S, Tavtigian SV, Scoazec JY, Herceg Z.

PLoS One. 2010 Mar 17;5(3):e9749. doi: 10.1371/journal.pone.0009749.

14.

SOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma.

Zhang X, You Q, Zhang X, Chen X.

Int J Mol Sci. 2015 Sep 18;16(9):22662-75. doi: 10.3390/ijms160922662.

15.

RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients.

Ara├║jo OC, Rosa AS, Fernandes A, Niel C, Villela-Nogueira CA, Pannain V, Araujo NM.

PLoS One. 2016 Apr 14;11(4):e0153796. doi: 10.1371/journal.pone.0153796. eCollection 2016.

16.

[Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].

Lou C, Yang B, Gao YT, Wang YJ, Nie FH, Yuan Q, Zhang CL, Du Z.

Zhonghua Zhong Liu Za Zhi. 2008 Nov;30(11):831-6. Chinese.

PMID:
19173828
17.

Deregulation of RB1 expression by loss of imprinting in human hepatocellular carcinoma.

Anwar SL, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, Kreipe H, Lehmann U.

J Pathol. 2014 Aug;233(4):392-401. doi: 10.1002/path.4376. Epub 2014 Jun 16.

PMID:
24838394
18.

Pharmacological unmasking microarray approach-based discovery of novel DNA methylation markers for hepatocellular carcinoma.

Jung N, Won JK, Kim BH, Suh KS, Jang JJ, Kang GH.

J Korean Med Sci. 2012 Jun;27(6):594-604. doi: 10.3346/jkms.2012.27.6.594. Epub 2012 May 26.

19.

Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.

Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T, Kaneto H, Iku S, Ozeki I, Karino Y, Satoh T, Toyota J, Satoh M, Endo T, Imai K.

Oncogene. 2000 Nov 2;19(46):5298-302.

20.

Correlation of CpG island methylator phenotype with poor prognosis in hepatocellular carcinoma.

Cheng Y, Zhang C, Zhao J, Wang C, Xu Y, Han Z, Jiang G, Guo X, Li R, Bu X, Wu M, Wei L.

Exp Mol Pathol. 2010 Feb;88(1):112-7. doi: 10.1016/j.yexmp.2009.10.008. Epub 2009 Oct 29.

PMID:
19879258

Supplemental Content

Support Center